Process for preparing optically active 1,2-diols
    1.
    发明授权
    Process for preparing optically active 1,2-diols 失效
    光学活性1,2-二醇的制备方法

    公开(公告)号:US06569652B1

    公开(公告)日:2003-05-27

    申请号:US09486442

    申请日:2000-02-25

    IPC分类号: C12P1302

    CPC分类号: C12P7/22

    摘要: The present invention relates to a process for producing optically active diols represented by the general formula (II): wherein R1 represents (CH2)n, CH═CH, O, S or NH whereupon n is an integer of 1 to 4, and R2 represents hydrogen, C1-6 alkyl, C1-6 alkoxy, (C1-6 alkoxy)-carbonyl, hydroxy, carboxy, halogen, nitro or amino, which comprises treating compounds represented by the general formula (I): wherein R1 and R2 have the same meanings as defined above, with a culture of a microorganism belonging to the genus Rhodococcus, Bacillus, Brevibacterium or Gordona and being capable of stereoselectively diolating a double bond in ring A, or with a culture of Mortierella vinacea, or with said microorganism itself, or with a treated material from said microorganism.

    摘要翻译: 本发明涉及由通式(II)表示的光学活性二醇的制备方法:其中R1表示(CH2)n,CH = CH,O,S或NH,其中n为1〜4的整数,R2为 代表氢,C 1-6烷基,C 1-6烷氧基,(C 1-6烷氧基) - 羰基,羟基,羧基,卤素,硝基或氨基,其包括处理由通式(I)表示的化合物:其中R1和R2具有 与上述定义相同,具有属于红球菌属,芽孢杆菌属,短杆菌属或戈多纳属的微生物的培养物,并且能够立体选择性地使环A中的双键二醇化,或与被孢霉属(Mortierella vinacea)的培养物或与所述微生物本身 ,或与来自所述微生物的处理物质混合。

    Process for producing xanthine derivatives with bacteria and fungi
    3.
    发明授权
    Process for producing xanthine derivatives with bacteria and fungi 失效
    用细菌和真菌生产黄嘌呤衍生物的方法

    公开(公告)号:US6107064A

    公开(公告)日:2000-08-22

    申请号:US581533

    申请日:1996-01-17

    摘要: The present invention relates to a process for producing a xanthine derivative represented by formula (II), comprising converting a xanthine derivative represented by formula (I) {hereinafter, referred to as Compound (I)}: ##STR1## (wherein R.sup.1 and R.sup.2 independently represent hydrogen, or hydroxy-substituted, oxo-substituted, or unsubstituted lower alkyl) into a xanthine derivative represented by formula (II) {hereinafter, referred to as Compound (II)}: ##STR2## (wherein R.sup.3 and R.sup.4 independently represent hydrogen, or hydroxy-substituted, oxo-substituted, or unsubstituted lower alkyl; R.sup.5 and R.sup.6 independently represent hydrogen, hydroxy, or oxo; with the proviso that R.sup.5 and R.sup.6 are both hydrogen, at least one of R.sup.3 and R.sup.4 is hydroxy-substituted or oxo-substituted lower alkyl; and X and Y both represent hydrogen or are combined with each other to form a single bond) in the presence of an enzyme source for catalyzing hydroxylation or carbonylation of Compound (I) into Compound (II), and collecting the produced Compound (II).

    摘要翻译: PCT No.PCT / JP95 / 00929 Sec。 371日期1996年1月17日 102(e)日期1996年1月17日PCT提交1995年5月16日PCT公布。 公开号WO95 / 31460 日本特开平9-1252号公报发明内容本发明涉及由式(II)表示的黄嘌呤衍生物的制造方法,其特征在于,将由式(I)表示的黄嘌呤衍生物{以下称为化合物(I)} 和R2独立地表示氢或羟基取代的,取代或未取代的低级烷基)转化为由式(II)表示的黄嘌呤衍生物(以下称为化合物(II)}:(其中R 3和R 4独立地表示氢 或羟基取代的,取代或未取代的低级烷基; R 5和R 6独立地表示氢,羟基或氧代;条件是R 5和R 6都是氢,R 3和R 4中的至少一个是羟基取代的或 氧代取代的低级烷基; X和Y均表示氢或彼此结合形成单键)在用于催化化合物(I)羟化或羰基化成化合物(II)的酶源的存在下,以及大学 将所制备的化合物(II)。

    .beta.-lactam compound and a pharmaceutical composition containing the
same
    4.
    发明授权
    .beta.-lactam compound and a pharmaceutical composition containing the same 失效
    β-内酰胺化合物和含有该β-内酰胺的药物组合物

    公开(公告)号:US4694001A

    公开(公告)日:1987-09-15

    申请号:US674710

    申请日:1984-11-26

    摘要: .beta.-Lactam compounds represented by the general formula: ##STR1## (wherein X represents CH.sub.2, S or O; Y represents a hydroxyl group, a lower alkanoyloxy group or a lower alkoxycarbonyloxy group; W is a group represented by CH.sub.2, NH, ##STR2## A is a phenyl group, a naphthyl group, or a monocyclic or dicyclic heterocyclic group, respectively substituted by (Y).sub.n ; R.sub.4 and R.sub.5 each are a hydrogen atom, a lower alkyl group, or a cycloalkylidene group with a carbon atom combined therewith; l is 0 or an integer of 1, 2 or 3; m is 0 or 1; n is an integer of 1, 2, 3, 4 or 5; and R.sub.1, R.sub.2 and R.sub.3 are groups often used in the conventional .beta.-lactam compounds) have strong antimicrobial activities against a wide range of Gram positive and negative bacteria; particularly Gram negative bacteria including Pseudomonas aeruginosa, Pseudomonas sepatia and various Enterobacters.

    摘要翻译: 由以下通式表示的β-内酰胺化合物:其中X表示CH 2,S或O; Y表示羟基,低级烷酰氧基或低级烷氧基羰氧基; W表示为CH 2,NH, 图像A是分别被(Y)n取代的苯基,萘基或单环或二环杂环基; R 4和R 5各自为氢原子,低级烷基或具有碳原子的亚环烷基 l是0或1,2或3的整数; m是0或1; n是1,2,3,4或5的整数; R 1,R 2和R 3是通常用于常规的基团 β-内酰胺化合物)对广泛的革兰氏阳性和阴性细菌具有很强的抗微生物活性; 特别是革兰氏阴性细菌,包括铜绿假单胞菌,假单胞菌分离菌和各种肠道特征。

    .beta.-Phenoxy or substituted phenoxy ethanol compounds
    6.
    发明授权
    .beta.-Phenoxy or substituted phenoxy ethanol compounds 失效
    {62-苯氧基或取代的苯氧基乙醇化合物

    公开(公告)号:US4016186A

    公开(公告)日:1977-04-05

    申请号:US527417

    申请日:1974-11-26

    IPC分类号: C07C69/003 C07C69/76

    CPC分类号: C07C69/003

    摘要: Novel .beta.-phenoxy- or substituted phenoxy-ethanol compounds or esters thereof expressed by the formula ##STR1## wherein R.sup.1 is a hydrogen atom or an alkyl group, R.sup.2 is a hydrogen atom or a substituent, Y is --OH group or group ##STR2## R.sup.3 is an alkyl group, and n is an integer of 1 to 3. These compounds have juvenile hormone activities, and are useful for hormonal pest control and increased production of silkworm cocoons.

    摘要翻译: 新的β-苯氧基 - 或取代的苯氧基 - 乙醇化合物或其由下式表示的酯其中R 1是氢原子或烷基,R 2是氢原子或取代基,Y是-OH基团或基团 R3为烷基,n为1〜3的整数。